2009, Number 2
<< Back Next >>
Revista Cubana de Información en Ciencias de la Salud (ACIMED) 2009; 20 (2)
The metabolic syndrome: a high risk for sedentary persons
Miguel SPE
Language: Spanish
References: 12
Page: 1-8
PDF size: 95.64 Kb.
ABSTRACT
The metabolic syndrome comprises a group of ischemic cardiopaties risk factors and the type 2 mellitus diabetes. It is frequently associated to obesity and sedentary lifestyle. The characteristics of this syndrome are central obesity, atherogenic dyslipidemia, high figures of arterial blood pressure, insulin resistance, trend to a low grade inflammation and a prothombotic state. It is treated mainly with changes in life style, healthy diet, physical exercises, and elimination of toxic habits. The comorbidities are treated with medications. The fight against sedentary habits is an important part of its treatment.
REFERENCES
Kang YH, Min HG, Kim IJ, Kim YK, Son SM. Comparison of alanine aminotransferase, white blood cell count and uric acid in their association with metabolic syndrome: A study of corean adults. Endocr J. 2008;55 (6):1093-102.
Liberopoulos EN, Mikhailidis DP, Elisaf MS. Diagnosis and management of the metabolic syndrome in obesity. Obes Rev. 2005;6(4)283-96.
Giles TD, Sander GE. Pathophysiologic, diagnostic and therapeutic aspects of the metabolic syndrome. J Clin Hypertens. 2005;7(11):669-78.
Cornejo Barrera J, Llanas Rodríguez JD, Alcázar Castañeda C. Acciones, programas, proyectos y políticas para disminuir el sedentarismo y promover el ejercicio en los niños. Bol Med Hosp Infant Mex. 2008;65(6):616-25.
Ricciardi R. Sedentarism: A concept analysis. Nursing Forum. 2005;40(3):79-87.
Lemon SC, Zapka J, Wenjun L, Estabrook B, Magner R, Rosal MC. Perceptions of worksite support and employee obesity, activity and diet. Am J Health Behav. 2009;33(3):299-308.
Comisión Nacional Técnica Asesora del Programa de Hipertensión Arterial. Hipertensión arterial. Guía para la prevención, diagnóstico y tratamiento. La Habana: Editorial Ciencias Médicas. 2008.
Calderín Bouza RO, Prieto Valdés M, Cabrera Rode E. Síndrome de insulinorresistencia en niños y adolescentes. Rev Cubana Endocrinol. 2007;18(2). Disponible en: http://web.ebscohost.com/ehost/pdf?vid=1&hid=104&sid=0b148ddd-9f2e-4b8d-965b-830e70e83746%40sessionmgr102 [Consultado: 22 de junio de 2009].
Ferns G, Keti V. HDL-cholesterol modulation and its impact on the management of cardiovascular risk. Ann Clin Biochem. 2008;45:122-8.
Tilg H, Moschen AR. Inflammatory mechanisms in the regulation of insulin resistance. Mol Med. 2008;14(3-4):222-31.
Powers E, Saultz J, Hamilton A. Which lifestyle interventions effectively lower LDL cholesterol? J Fam Pract. 2007;56(6):483-5.
Aguilar Hernández I, Vázquez Aguilar JL, Benítez Maqueira B, Perera Milián LS, Pérez Hernández I. Influencia del ejercicio físico en algunos factores de riesgo de la cardiopatía isquémica. Rev Cubana Med Gen Integr. 2007;23(2). Disponible en: http://web.ebscohost.com/ehost/pdf?vid=1&hid=103&sid=7bfb8fff-e191-42bf93d6151504fdc097%40sessionmgr102 [Consultado: 22 de junio de 2009].